Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,436
Total Claims
$1.7M
Drug Cost
1,209
Beneficiaries
$1,370
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+250%
Opioid rate vs peers
7.8% vs 2.2% avg
-3%
Cost per patient vs peers
$1,370 vs $1,411 avg
-11%
Brand preference vs peers
9.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 250% above Internal Medicine peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
7.8%
Opioid Rate
1,758
Opioid Claims
$98K
Opioid Cost
12.1%
Long-Acting Rate
Brand vs Generic
Brand: 2,107 claims · $1.2M
Generic: 20,231 claims · $409K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 127 | $158K |
| Apixaban | 146 | $139K |
| Etanercept | 12 | $92K |
| Tirzepatide | 69 | $82K |
| Dulaglutide | 45 | $65K |
| Rivaroxaban | 56 | $46K |
| Empagliflozin | 28 | $45K |
| Dapagliflozin Propanediol | 21 | $36K |
| Oxycodone Hcl | 36 | $34K |
| Rsvpref3 Antigen/As01e/Pf | 97 | $29K |
| Linaclotide | 42 | $27K |
| Mirabegron | 26 | $23K |
| Hydrocodone/Acetaminophen | 734 | $23K |
| Insulin Aspart Prot/Insuln Asp | 19 | $21K |
| Insulin Lispro Protamin/Lispro | 28 | $21K |
Prescribing Profile
Patient Profile
75
Avg Age
57%
Female
1.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data